Technical Analysis for SLRX - Salarius Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Gapped Down | Weakness | 0.00% | |
20 DMA Support | Bullish | -7.08% | |
50 DMA Support | Bullish | -7.08% | |
Hammer Candlestick | Bullish | -7.08% | |
Crossed Above 20 DMA | Bullish | -4.97% | |
Outside Day | Range Expansion | -4.97% |
Alert | Time |
---|---|
Possible NR7 | about 19 hours ago |
Possible Inside Day | about 19 hours ago |
Gap Down Partially Closed | about 22 hours ago |
50 DMA Support | about 22 hours ago |
1.5x Volume Pace | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/25/2024
Salarius Pharmaceuticals, Inc. a clinical-stage oncology company, develops therapies for the treatment of patients with various cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Solid Tumors Clinical Development Oncology Breast Cancer Prostate Cancer Ovarian Cancer Treatment Of Breast Cancer Sarcoma Advanced Solid Tumors
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Solid Tumors Clinical Development Oncology Breast Cancer Prostate Cancer Ovarian Cancer Treatment Of Breast Cancer Sarcoma Advanced Solid Tumors
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.68 |
52 Week Low | 0.5002 |
Average Volume | 27,233 |
200-Day Moving Average | 0.83 |
50-Day Moving Average | 0.60 |
20-Day Moving Average | 0.63 |
10-Day Moving Average | 0.65 |
Average True Range | 0.06 |
RSI (14) | 46.24 |
ADX | 43.6 |
+DI | 25.55 |
-DI | 9.23 |
Chandelier Exit (Long, 3 ATRs) | 0.60 |
Chandelier Exit (Short, 3 ATRs) | 0.71 |
Upper Bollinger Bands | 0.71 |
Lower Bollinger Band | 0.55 |
Percent B (%b) | 0.32 |
BandWidth | 24.98 |
MACD Line | 0.01 |
MACD Signal Line | 0.02 |
MACD Histogram | -0.005 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.68 | ||||
Resistance 3 (R3) | 0.69 | 0.67 | 0.67 | ||
Resistance 2 (R2) | 0.67 | 0.65 | 0.66 | 0.66 | |
Resistance 1 (R1) | 0.64 | 0.64 | 0.63 | 0.63 | 0.66 |
Pivot Point | 0.62 | 0.62 | 0.61 | 0.61 | 0.62 |
Support 1 (S1) | 0.59 | 0.60 | 0.58 | 0.58 | 0.55 |
Support 2 (S2) | 0.57 | 0.59 | 0.56 | 0.55 | |
Support 3 (S3) | 0.54 | 0.57 | 0.54 | ||
Support 4 (S4) | 0.53 |